Suscríbete a nuestras actualizaciones (en inglés) aquí para estar al tanto de los últimos avances y actualizaciones en materia de propiedad intelectual.
Discover why some of the most valuable patents in advanced materials, batteries, chemicals and green technologies emerge during scale-up from lab success to commercial manufacturing.
Learn the key differences between EPO oppositions and UPC revocation actions, from filing windows and procedural timelines to costs, scope and strategic considerations when challenging European patent
From ownership and licensing to patents and publications, effective IP strategy is vital for university spin-outs. Learn how to protect innovation and support commercial success.
The Enlarged Board's G 1/25 decision confirms description amendments are only needed where unresolved inconsistencies with the claims cause non-compliance with the EPC.
An EPO Board of Appeal decision reinforces the lessons of G 1/19. Careful claim drafting for computer-modelling inventions is essential to establish inventive step and preserve amendment options.
As solid-state battery patent filings surge, start-ups must protect innovation while managing freedom-to-operate risks. Discover how a robust IP strategy can support investment, growth and commercial
A recent EPO Board of Appeal decision confirms that applicants can correct errors in grant texts through appeal, but may still have to pay the appeal fee if they failed to identify the mistake earlier
A recent EPO appeal decision highlights the risks of claim alternatives, confirming that each alternative must independently meet sufficiency requirements.
Learn how chemistry start-ups can avoid 10 common patent portfolio mistakes and build an IP strategy that protects innovation, attracts investors and supports long-term commercial success.
Explore how major biotech and pharmaceutical jurisdictions approach double patenting and divisional applications, and discover strategies for building stronger global patent portfolios.
A recent UPC decision highlights the risks of delaying an opt out. Learn why early action may be essential to keep European patents outside UPC jurisdiction.
Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.
Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.
EPO patent filings show strong growth in materials, food technology, coatings and surface technologies, highlighting innovation driven by sustainability and advanced manufacturing.
Discover the key patent portfolio questions investors ask during IP due diligence and how chemistry and materials companies can strengthen investor confidence and support fundraising success.
New UK IPO guidance following the Emotional Perception AI ruling brings greater clarity to patent examination, aligning UK practice with the EPO and impacting AI, software and quantum computing invent
Discover how Tyruko compares with Tysabri, including biosimilar approval, manufacturing and formulation differences, patent considerations and the investigation into reported adverse patient outcomes.
Suscríbete a nuestras actualizaciones (en inglés) aquí para estar al tanto de los últimos avances y actualizaciones en materia de propiedad intelectual.
